Dycom Industries, Inc. to Host Fiscal 2026 Third Quarter Results Conference Call

(NYSE:DY), WEST PALM BEACH, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) — Dycom Industries, Inc. (NYSE: DY) will host a conference call to discuss fiscal 2026 third quarter results on Wednesday, November 19, 2025, at 9:00 a.m. ET. Dycom will issue a press release reporting its results earlier that morning. Interested parties may participate in the […]

Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025

(NASDAQ:ITRM), DUBLIN, Ireland and CHICAGO, Nov. 07, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (Company), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that the Company will release its third quarter 2025 financial results

Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting(R) 2025

(NASDAQ:AVIR), BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced the presentation of new modeling data predicting that the Company's combination regimen of bemnifosbuvir (BEM), a nucleotide analog polymerase

Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting(R)

(NASDAQ:ASMB), – Phase 1b data demonstrating favorable safety and tolerability profile and potent reductions in viral nucleic acids highlighted in late-breaking poster presentation – SOUTH SAN FRANCISCO, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced Phase 1b clinical data

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

(NASDAQ:CNTA), BOSTON and LONDON, Nov. 07, 2025 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the following investor conferences: Event: Guggenheim 2nd Annual Healthcare Innovation ConferenceDate: Wednesday, November 12, 2025Fireside

Vor Bio to Participate in Upcoming Investor Conferences

(NASDAQ:VOR), BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in the following upcoming investor conferences: TD Cowen Virtual Immunology & Inflammation SummitFireside Chat: Wednesday, November 12, 2025, at 2:30pm ET 8th Annual Evercore Healthcare ConferenceFireside Chat:

ESET to aid MSPs by integrating with ConnectWise Asio

The ESET PROTECT console plugin for ConnectWise Asio opens up more options for MSPs. This integration empowers MSPs with better tools to perform their most common tasks more easily, saving them time while improving their legal and insurance requirements. MSP customers benefit thanks to easier issue solution and deeper automation options made available via this

TechnoMile Unveils Next-Gen AI Platform and Agentic Innovations at Elevate25

The TechnoMile Platform and domain-trained AI agents deliver automation, tailored workflows, and real-time insights to help federal contractors streamline operations and accelerate growth. TechnoMile, a leading provider of transformative, AI-enabled cloud solutions that empower companies to find, pursue, win, and retain more business with the government from go-to-market through contract closeout, unveiled its latest product

TEEL Construction Expands Regional Presence with New Frederick, MD Office

TEEL Construction, Inc., a Fairfax, VA-based general contracting firm specializing in commercial construction across the East Coast, is proud to announce the opening of its new office in Frederick, Maryland. This satellite location complements TEEL's Fairfax headquarters and supports the company's continued growth throughout Maryland and surrounding markets. https://mma.prnewswire.com/media/2816197/TEEL_Construction_Logo.jpg “Our Frederick office strengthens our ability

Brunswick Collision Center Opens Its Doors to the Community

Brunswick Collision Center is bringing trusted collision repair and a customer-first experience to Brunswick and the surrounding region, combining expert craftsmanship with a strong commitment to community values. https://mma.prnewswire.com/media/2807685/Brunswick_Main_Street___Brunswick_collision_center.jpg Specializing in collision repair and auto body services, Brunswick Collision Center also assists clients in navigating insurance claims, making a stressful process smoother and more transparent.

Scroll to Top